Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06006962 · ClinicalTrials.gov registry record · NA

Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP)

A NA study of Cognitive Aging, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT06006962: Recruiting NA study of Cognitive Aging, sponsored by VA Office of Research and Development.

NCT06006962 is a NA study of Cognitive Aging that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 128 participants, below the 509-participant average among 5 other Cognitive Aging trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06006962, a NA study of Cognitive Aging, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn about the effects of AgeWISE-Action Plan (AgeWISE-AP), a 20-week program designed to provide education and individualized planning with a goal of improving brain health.

Primary Outcome

Community Healthy Activities Model Program for Seniors Questionnaire (CHAMPS) is a 41-item scale that explores the frequency and duration of light, moderate, and vigorous physical activities assessed using weekly frequency and duration.

Conditions Studied

Interventions

  • OTHER Aging Well through Interactions and Scientific Education - Action Plan

Study Locations (1)

Massachusetts

  • VA Bedford HealthCare System, Bedford, MA - Bedford

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2024-01-01
Est. Completion 2027-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06006962 shows while recruiting

NCT06006962 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 509-participant average among 5 other Cognitive Aging trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Cognitive Aging appearing as the primary indexed condition, and to 1 intervention - of which Aging Well through Interactions and Scientific Education - Action Plan is the first listed.

NCT06006962 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06006962 about?

NCT06006962 is a clinical study titled "Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP)". The purpose of this study is to learn about the effects of AgeWISE-Action Plan (AgeWISE-AP), a 20-week program designed to provide education and individualized planning with a goal of improving brain health.

What is the current status of trial NCT06006962?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2024-01-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06006962 study?

This clinical trial studies the following conditions: Cognitive Aging.

What interventions are being tested in trial NCT06006962?

The interventions under investigation include: Aging Well through Interactions and Scientific Education - Action Plan (OTHER).

Who is sponsoring clinical trial NCT06006962?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06006962 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06006962, the US trial registry maintained by the National Library of Medicine. NCT06006962 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.